Status:
UNKNOWN
Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Gastroesophageal Varices
Portal Hypertension
Eligibility:
All Genders
18-75 years
Brief Summary
Gastroesophageal varices are a complication of portal hypertension in cirrhosis.Endoscopy is an unsatisfactory screening test.In this prospective clinical study,we will enroll patients with cirrhosis ...
Eligibility Criteria
Inclusion
- The age ranged from 18 to 75 years.
- Clinical or pathological diagnosis of cirrhosis;
- Electronic gastroscopy is planned;
- To agree and sign the informed consent;
Exclusion
- Hepatocellular carcinoma or other malignant tumors have been or are currently diagnosed;
- Orthotopic liver transplantation patients;
- Patients who have undergone transjugular intrahepatic portosystemic shunt (TIPS),or previous surgical shunt;
- Pregnant women;
- Neurological or psychiatric disorders;
Key Trial Info
Start Date :
April 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2021
Estimated Enrollment :
616 Patients enrolled
Trial Details
Trial ID
NCT04123509
Start Date
April 9 2019
End Date
January 31 2021
Last Update
October 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China, 510515